Detalhe da pesquisa
1.
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study.
J Clin Microbiol
; 60(3): e0236221, 2022 03 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35170980
2.
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
Antimicrob Agents Chemother
; 65(11): e0036421, 2021 10 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34460307
3.
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa.
Eur Respir J
; 51(6)2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29724920
4.
Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa".
Eur Respir J
; 56(1)2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32703820
5.
Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household.
Open Forum Infect Dis
; 10(3): ofad087, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36910692
6.
Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study.
Lancet Microbe
; 4(7): e506-e515, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37295446
7.
Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa.
Trop Med Infect Dis
; 7(2)2022 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35202216
8.
Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients.
Pediatr Infect Dis J
; 40(5): e191-e192, 2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33847295
9.
"This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis.
PLoS One
; 16(10): e0251482, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34662887
10.
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study.
Lancet Microbe
; 2(11): e584-e593, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34766068
11.
Household contact management for rifampicin-resistant tuberculosis.
Lancet Glob Health
; 10(10): e1387, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36113520
12.
DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
PLoS One
; 12(5): e0178054, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28542441
13.
Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa.
Lancet Respir Med
; 10(6): 542-543, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35338838
14.
Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa.
Trans R Soc Trop Med Hyg
; 109(7): 425-32, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25979526
15.
Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa.
Open Forum Infect Dis
; 2(1): ofv014, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26034764
16.
Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.
PLoS One
; 10(3): e0118919, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25785451
17.
Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success.
PLoS One
; 10(11): e0142873, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26555134